After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Zentalis Pharmaceuticals Inc is $87.06M. A total of 0.75 million shares were traded on the day, compared to an average of 831.74K shares.
In the most recent transaction, Myers Scott Dunseth bought 21,000 shares of ZNTL for 1.40 per share on Apr 30 ’25. After the transaction, the Director now owns 281,192 company shares. In a previous transaction on Feb 06 ’25, Bruns Ingmar bought 20,000 shares at 2.28 per share. ZNTL shares that Chief Medical Officer owns now total 36,629.
Among the insiders who bought shares, Cam Gallagher acquired of 687 shares on Feb 11 ’25 at a per-share price of $2.00. In another insider transaction, Vultaggio Vincent sold 2,615 shares at $1.71 per share on Feb 03 ’25. Company shares held by the PAO and Interim PFO now total 189,826.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ZNTL has a high of $13.00 and a low of $1.01.
As of this writing, ZNTL has an earnings estimate of -$0.51 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.43 per share and a lower estimate of -$0.81.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ZNTL’s latest balance sheet shows that the firm has $339.89M in Cash & Short Term Investments as of fiscal 2021. There were $44.46M in debt and $43.94M in liabilities at the time. Its Book Value Per Share was $4.11, while its Total Shareholder’s Equity was $364.48M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
